MedTrace Logo

Prospective Memory in Parkinson's Disease

NCT00913640 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2022-05-06

No results posted yet for this study

Summary

The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better estimate prospective memory function in PD patients' everyday (chronically treated) life.

Conditions

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Tamara G Hershey, Ph.D. · Washington University School of Medicine

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-18
Primary Completion
2010-08-27
Completion
2010-08-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913640 on ClinicalTrials.gov